Dr. Stefanski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
MMC 366
University of Minnesota
Minneapolis, MN 55455Phone+1 612-626-2961
Education & Training
- University of MinnesotaFellowship, Pediatric Hematology/Oncology, 2007 - 2010
- University of MinnesotaResidency, Pediatrics, 2004 - 2007
- University of Minnesota Medical SchoolClass of 2004
Certifications & Licensure
- MN State Medical License 2006 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- 46 citationsA Spontaneous CD8 T Cell-Dependent Autoimmune Disease to an Antigen Expressed Under the Human Keratin 14 PromoterMaureen A. McGargill, Dita Mayerova, Heather E. Stefanski, Brent H. Koehn, Evan A. Parke
Journal of Immunology. 2002-08-15 - 3222 citationsTisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic LeukemiaShannon L. Maude, Theodore W. Laetsch, Jochen Buechner, S. Rives, Michael Boyer
The New England Journal of Medicine. 2018-01-31 - 85 citationsThree-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.Theodore W Laetsch, Shannon L Maude, Susana Rives, Hidefumi Hiramatsu, Henrique Bittencourt
Journal of Clinical Oncology. 2023-03-20
Journal Articles
- Thymic Epithelial Cell Support of Thymopoiesis Does Not Require KlothoBruce R Blazar, Heather E Stefanski, Sarah L Parker, Jakub Tolar, The Journal of Immunology
Press Mentions
- Magenta Therapeutics Highlights Recent Progress and Expected Timing of 2021 Milestones, Including Four Ongoing and Planned Clinical TrialsJanuary 11th, 2021
- National Marrow Donor Program® (NMDP)/Be the Match® Partners with New York Blood Center Enterprises Comprehensive Cell Solutions and Vitalant’s Cell Therapy Lab; Expands Access to TransplantSeptember 27th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: